Neutrophil-lymphocyte ratio as a predictive marker for progression free survival in patients with advanced cutaneous squamous cell carcinoma prior to Cemiplimab treatment – a real-life setting - I. Ciobotariu; A. Di Stefani; A. Paradisi; L. Di Nardo; K. Peris (EJC Skin Cancer)